Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease (COMPASS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01776424
Recruitment Status : Active, not recruiting
First Posted : January 28, 2013
Last Update Posted : June 29, 2018
Hamilton Health Sciences Corporation, Population Health Research Institute
Janssen Research & Development, LLC
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : July 21, 2017
  Estimated Study Completion Date : June 30, 2021
Publications automatically indexed to this study by Identifier (NCT Number):